Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma.
Song WangXueyou MaYufan YingJiazhu SunZitong YangJiangfeng LiKe JinXiao WangBo XieXiangyi ZhengBen LiuLiping XiePublished in: Cancer cell international (2021)
ARNTL2 is an independent adverse predictor of ccRCC patient survival. High expression level of ARNTL2 is associated with immune infiltration, and may be a novel therapeutic target in ccRCC.